Literature DB >> 26940163

Relating Retinal Morphology and Function in Aging and Early to Intermediate Age-related Macular Degeneration Subjects.

Monica B Sevilla1, Gerald McGwin2, Eleonora M Lad1, Mark Clark3, Eric L Yuan1, Sina Farsiu4, Christine A Curcio3, Cynthia Owsley3, Cynthia A Toth5.   

Abstract

PURPOSE: To evaluate relationships between age-related macular degeneration (AMD) morphology on spectral-domain optical coherence tomography (SDOCT) and visual function.
DESIGN: Cross-sectional, observational.
METHODS: From the Alabama Study on Early AMD baseline visit, visual acuity, cone-mediated sensitivity, rod-mediated dark adaptation, and SDOCT were obtained in 1 eye per subject with no apparent retinal aging (n = 15), normal aging (n = 15), early AMD (n = 15), and intermediate AMD (n = 46). The volumes of retinal pigment epithelium (RPE)-drusen complex, RPE-drusen complex abnormal thinning, RPE-drusen complex abnormal thickening, and inner and outer retina were calculated in specified regions using semi-automated SDOCT segmentation.
RESULTS: Better cone-mediated sensitivity was associated with greater RPE-drusen complex volume (r = 0.34, P < .001) and less RPE-drusen complex abnormal thinning volume (r = -0.31, P = .003). Longer rod-mediated dark adaptation time, the duration for rod-mediated sensitivity to recover from photo-bleach exposure, correlated with lower RPE-drusen complex volume (r = -0.34, P = .005) and greater RPE-drusen complex abnormal thinning volume (r = 0.280, P = .023). In 19 eyes with subretinal drusenoid deposits (SDD) vs 47 eyes without SDD, rod-mediated dark adaptation time was longer (mean ± SD 13.5 ± 7.0 vs 10.2 ± 3.1 minutes, P = .004), RPE-drusen complex abnormal thinning volume was greater (P < .0001), and visual acuity and cone sensitivity did not differ.
CONCLUSION: Decreased function relates to structural markers on SDOCT in AMD. Because the RPE-drusen complex includes the interdigitation of outer segments and RPE apical processes and SDD in eyes with AMD, slower dark adaptation might be related to structural abnormalities of the RPE, the RPE-photoreceptor interface, or both.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26940163      PMCID: PMC5567819          DOI: 10.1016/j.ajo.2016.02.021

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  39 in total

Review 1.  Spare the rods, save the cones in aging and age-related maculopathy.

Authors:  C A Curcio; C Owsley; G R Jackson
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-07       Impact factor: 4.799

2.  Dynamic soft drusen remodelling in age-related macular degeneration.

Authors:  R Theodore Smith; Mahsa A Sohrab; Nicole Pumariega; Yue Chen; Jian Chen; Noah Lee; Andrew Laine
Journal:  Br J Ophthalmol       Date:  2010-06-07       Impact factor: 4.638

3.  Quantitative classification of eyes with and without intermediate age-related macular degeneration using optical coherence tomography.

Authors:  Sina Farsiu; Stephanie J Chiu; Rachelle V O'Connell; Francisco A Folgar; Eric Yuan; Joseph A Izatt; Cynthia A Toth
Journal:  Ophthalmology       Date:  2013-08-29       Impact factor: 12.079

4.  RefMoB, a Reflectivity Feature Model-Based Automated Method for Measuring Four Outer Retinal Hyperreflective Bands in Optical Coherence Tomography.

Authors:  Douglas H Ross; Mark E Clark; Pooja Godara; Carrie Huisingh; Gerald McGwin; Cynthia Owsley; Katie M Litts; Richard F Spaide; Kenneth R Sloan; Christine A Curcio
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-07       Impact factor: 4.799

5.  Delays in rod-mediated dark adaptation in early age-related maculopathy.

Authors:  C Owsley; G R Jackson; M White; R Feist; D Edwards
Journal:  Ophthalmology       Date:  2001-07       Impact factor: 12.079

6.  Subretinal drusenoid deposits in non-neovascular age-related macular degeneration: morphology, prevalence, topography, and biogenesis model.

Authors:  Christine A Curcio; Jeffrey D Messinger; Kenneth R Sloan; Gerald McGwin; Nancy E Medeiros; Richard F Spaide
Journal:  Retina       Date:  2013-02       Impact factor: 4.256

7.  Twelve-month natural history of dark adaptation in patients with AMD.

Authors:  Gregory R Jackson; Mark E Clark; Ingrid U Scott; Laura E Walter; David A Quillen; Mitchell G Brigell
Journal:  Optom Vis Sci       Date:  2014-08       Impact factor: 1.973

Review 8.  Photoreceptor degeneration and dysfunction in aging and age-related maculopathy.

Authors:  Gregory R Jackson; Cynthia Owsley; Christine A Curcio
Journal:  Ageing Res Rev       Date:  2002-06       Impact factor: 10.895

9.  Automatic segmentation of seven retinal layers in SDOCT images congruent with expert manual segmentation.

Authors:  Stephanie J Chiu; Xiao T Li; Peter Nicholas; Cynthia A Toth; Joseph A Izatt; Sina Farsiu
Journal:  Opt Express       Date:  2010-08-30       Impact factor: 3.894

10.  A short-duration dark adaptation protocol for assessment of age-related maculopathy.

Authors:  Gregory R Jackson; John G Edwards
Journal:  J Ocul Biol Dis Infor       Date:  2008-05-06
View more
  16 in total

1.  ASSOCIATION BETWEEN VISUAL FUNCTION AND SUBRETINAL DRUSENOID DEPOSITS IN NORMAL AND EARLY AGE-RELATED MACULAR DEGENERATION EYES.

Authors:  David Neely; Anna V Zarubina; Mark E Clark; Carrie E Huisingh; Gregory R Jackson; Yuhua Zhang; Gerald McGwin; Christine A Curcio; Cynthia Owsley
Journal:  Retina       Date:  2017-07       Impact factor: 4.256

Review 2.  [Development and validation of novel clinical endpoints in intermediate age-related macular degeneration in MACUSTAR].

Authors:  Jan H Terheyden; Robert P Finger; Steffen Schmitz-Valckenberg; Hansjürgen Agostini; Claudia Dahlke; Laura Kuehlewein; Gabriele E Lang; Daniel Pauleikhoff; Armin Wolf; Michael K Boettger; Ulrich F O Luhmann; Friedrich Asmus; Frank G Holz
Journal:  Ophthalmologe       Date:  2019-12       Impact factor: 1.059

3.  Mesopic and dark-adapted two-color fundus-controlled perimetry in patients with cuticular, reticular, and soft drusen.

Authors:  Maximilian Pfau; Moritz Lindner; Martin Gliem; Julia S Steinberg; Sarah Thiele; Robert P Finger; Monika Fleckenstein; Frank G Holz; Steffen Schmitz-Valckenberg
Journal:  Eye (Lond)       Date:  2018-08-01       Impact factor: 3.775

4.  Retinal Layer Thicknesses in Early Age-Related Macular Degeneration: Results From the German AugUR Study.

Authors:  Caroline Brandl; Christiane Brücklmayer; Felix Günther; Martina E Zimmermann; Helmut Küchenhoff; Horst Helbig; Bernhard H F Weber; Iris M Heid; Klaus J Stark
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-04-01       Impact factor: 4.799

5.  Biomarkers for Nonexudative Age-Related Macular Degeneration and Relevance for Clinical Trials: A Systematic Review.

Authors:  Vivienne Fang; Maria Gomez-Caraballo; Eleonora M Lad
Journal:  Mol Diagn Ther       Date:  2021-08-25       Impact factor: 4.074

6.  Reticular Pseudodrusen Are Associated With More Advanced Para-Central Photoreceptor Degeneration in Intermediate Age-Related Macular Degeneration.

Authors:  Matt Trinh; Natalie Eshow; David Alonso-Caneiro; Michael Kalloniatis; Lisa Nivison-Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-10-03       Impact factor: 4.925

Review 7.  Biochemical Measurements of Free Opsin in Macular Degeneration Eyes: Examining the 11-CIS Retinal Deficiency Hypothesis of Delayed Dark Adaptation (An American Ophthalmological Society Thesis).

Authors:  Anne Hanneken; Thomas Neikirk; Jennifer Johnson; Masahiro Kono
Journal:  Trans Am Ophthalmol Soc       Date:  2017-08-22

8.  Natural History of Rod-Mediated Dark Adaptation over 2 Years in Intermediate Age-Related Macular Degeneration.

Authors:  Cynthia Owsley; Mark E Clark; Gerald McGwin
Journal:  Transl Vis Sci Technol       Date:  2017-06-05       Impact factor: 3.283

Review 9.  Spotlight on reticular pseudodrusen.

Authors:  Alessandro Rabiolo; Riccardo Sacconi; Maria Vittoria Cicinelli; Lea Querques; Francesco Bandello; Giuseppe Querques
Journal:  Clin Ophthalmol       Date:  2017-09-20

10.  Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention-MACUSTAR.

Authors:  Jan H Terheyden; Frank G Holz; Steffen Schmitz-Valckenberg; Anna Lüning; Matthias Schmid; Gary S Rubin; Hannah Dunbar; Adnan Tufail; David P Crabb; Alison Binns; Clara I Sánchez; Carel Hoyng; Philippe Margaron; Nadia Zakaria; Mary Durbin; Ulrich Luhmann; Parisa Zamiri; José Cunha-Vaz; Cecília Martinho; Sergio Leal; Robert P Finger
Journal:  Trials       Date:  2020-07-18       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.